Skip to main content
OpenTrials
Completed

NCT Number: NCT06575972

A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.

This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol Aftereffects Anxiety Anxiety Disorders Cognition Disorders Cognitive Dysfunction Cognitive Impairment Mental Disorders Neurocognitive Disorders

Age range

35 year–54 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 35-54, male or female
  • Regular alcohol consumption
  • Event planned within one month that involves alcohol consumption
  • Willingness to avoid new medications or supplements during the study period
  • Must confirm that they will not drive while under the influence of alcohol.

Exclusion criteria

  • Anyone not in good health.
  • Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
  • Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
  • Anyone who is pregnant, breastfeeding, or trying to conceive.
  • Anyone who cannot/ will not commit to the study protocol.
  • Anyone with a history of substance abuse.
  • Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration.
  • Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension.
  • History of severe reactions or sensitivity to alcohol.
  • Anyone currently taking glutathione.

Treatment and study plan

JoyRise Recovery Powder

Dietary Supplement

JoyRise Recovery Powder is a dietary supplement that contains Dihydromyricetin (DHM) and other natural ingredients. It is designed to mitigate the aftereffects of alcohol consumption. Participants will mix one serving in 8-12 oz of water and consume it the morning after alcohol consumption.

Placebo

Dietary Supplement

A placebo solution that is visually and tastefully similar to JoyRise Recovery Powder but contains no active ingredients. It will be mixed in 8-12 oz of water and consumed the morning after alcohol consumption.

Primary outcomes

  1. Reduction in Symptoms Associated with Alcohol Aftereffects

    Time frame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.

    Measurement of the reduction in alcohol aftereffects using the Alcohol Hangover Questionnaire (AHQ). Participants will self-report their symptoms, such as headache, nausea, and tiredness.

Secondary outcomes

  1. Improvement in Cognitive Function

    Time frame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.

    Measurement of cognitive function using Double Trouble (which assesses selective attention and processing speed). Participants will complete this assessment to determine any changes in cognitive function.

  2. Improvement in Cognitive Function

    Time frame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.

    Measurement of cognitive function using two cognitive tests: Feature Match (which assesses focus and processing). Participants will complete this assessment to determine any changes in cognitive function.

  3. Reduction in Feelings of Anxiousness

    Time frame: Baseline and 30 minutes after product consumption on the day following alcohol consumption.

    Measurement of reduction in feelings of anxiousness using self-reported questionnaires. Participants will rate their anxiety levels to determine if the product provides a calming effect.

  4. Increased User Satisfaction with Overall Well-being

    Time frame: Baseline and 4+ hours after product consumption on the day following alcohol consumption.

    Measurement of user satisfaction with overall well-being through self-reported questionnaires. Participants will rate their satisfaction with their physical and mental state post-alcohol consumption.

Sponsors and collaborators

Lead sponsor

Joyrise

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 28, 2024
Registry last updated
Aug 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.